Can a daily supplement help men clear HPV and boost fertility?

NCT ID NCT07320183

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests whether a daily dietary supplement containing EGCG, folic acid, vitamin B12, and hyaluronic acid can help men clear an active HPV infection and improve sperm health. The study involves 34 couples trying to conceive, where the male partner has HPV and the female partner does not. Half of the men will take the supplement for six months, while the other half receive no supplement. Researchers will check if more men in the supplement group test negative for HPV at the end of the study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dietary supplement containing EGCG, folic acid, vitamin B12, and hyaluronic acid

What this could lead to

If it works, this supplement could help clear HPV infection in men and improve fertility outcomes for couples trying to conceive.

What could go wrong

This is a very small pilot study (34 couples) with no blinding or placebo control, so results may not be reliable. Supplements are not a proven treatment for HPV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anogenital human papillomavirus infection human papilloma virus infection infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••